US Broker Ratings

Soleno Therapeutics (SLNO) Investor Outlook: Navigating the Hold Ratings with Promising EPS and Cash Flow

Soleno Therapeutics, Inc. (NASDAQ: SLNO), a pioneering biopharmaceutical company, has carved a niche in the biotechnology sector with its focus on developing therapeutics for rare diseases. Headquartered in Redwood City,..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Unpacking a Potential 13% Upside for Investors

Bausch + Lomb Corporation (NYSE: BLCO) stands as a venerable name in the eye health industry, with roots dating back to 1853. As a subsidiary of Bausch Health Companies Inc.,..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Exploring a 57% Upside Potential in the Biotech Sector

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is capturing investor attention in the biotechnology sector with its impressive potential for growth. Known for focusing on rare neuroendocrine diseases, this Boston-based company is..

Repligen Corporation (RGEN) Stock Analysis: Exploring a 55% Potential Upside for Investors

Repligen Corporation (NASDAQ: RGEN), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, is catching the eye of investors with its substantial growth potential...

Ionis Pharmaceuticals, Inc. (IONS): Investor Outlook Highlights 33.56% Potential Upside

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) is garnering attention from investors due to its compelling growth prospects in the biotechnology sector. With a market capitalization of $12.49 billion, Ionis is a..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating Through a 52.6% Revenue Growth Amidst a Challenging Valuation Landscape

Oscar Health, Inc. (NYSE: OSCR), a prominent player in the healthcare sector, has been making waves with its innovative approach to health insurance. As a healthcare technology company, Oscar Health..

Koninklijke Philips N.V. (PHG) Stock Analysis: Exploring a 24.45% Potential Upside in Healthcare Innovation

For investors seeking opportunities within the healthcare sector, Koninklijke Philips N.V. (NYSE: PHG) presents an intriguing proposition. With a market capitalization of $25.66 billion, this Dutch healthcare giant operates across..

Stevanato Group S.p.A. (STVN) Stock Analysis: Unpacking a Potential 37.89% Upside in the Healthcare Sector

Stevanato Group S.p.A. (NYSE: STVN), a notable player in the healthcare sector, specifically within the medical instruments and supplies industry, is drawing attention from investors with its promising growth potential...

Abbott Laboratories (ABT) Stock Analysis: Tapping Into a 35.73% Potential Upside

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector with a market cap of $152.25 billion, presents an intriguing case for investors seeking both stability and growth. As a..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Exploring the 30.95% Potential Upside

Sarepta Therapeutics, Inc. (SRPT), a prominent player in the biotechnology sector, continues to capture investor attention with its strategic focus on RNA-targeted therapeutics and gene therapies for rare diseases. As..

Tempus AI, Inc. (TEM) Stock Analysis: A Balanced Look at Its 45% Potential Upside

Tempus AI, Inc. (NASDAQ: TEM), a prominent player in the healthcare technology sector, presents a compelling opportunity for investors seeking growth in the ever-evolving health information services industry. With a..

Elevance Health, Inc. (ELV) Stock Analysis: Exploring a Promising 1.5% Potential Upside in the Healthcare Sector

Elevance Health, Inc. (NYSE: ELV), a major player in the U.S. healthcare plans industry, is attracting attention with its substantial market cap of $85.71 billion and a current stock price..

Hologic, Inc. (HOLX) Stock Analysis: Navigating Steady Growth in the Healthcare Sector

Hologic, Inc. (NASDAQ: HOLX) stands as a key player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $16.97 billion, this Massachusetts-based..

Krystal Biotech (KRYS) Investor Outlook: Robust Growth Prospects with 8.32% Potential Upside

Krystal Biotech, Inc. (NASDAQ: KRYS) is drawing significant attention in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $8.83 billion, this Pittsburgh-based company is at..

Takeda Pharmaceutical (TAK) Stock Analysis: Exploring a Promising 25.97% Upside Potential

Takeda Pharmaceutical Company Limited (NYSE: TAK), a titan in the healthcare sector, stands as a compelling investment opportunity for those eyeing the drug manufacturing industry. With a market capitalization of..

Integer Holdings Corporation (ITGR) Stock Analysis: Navigating Growth Amidst Valuation Challenges

Integer Holdings Corporation (NYSE: ITGR) is a notable player in the healthcare sector, specializing in medical devices. With its headquarters in Plano, Texas, the company has established a significant presence..

HCA Healthcare, Inc. (HCA) Stock Analysis: A Potential 29.66% Upside Amid Strong Analyst Confidence

HCA Healthcare, Inc. (NYSE: HCA), a titan in the medical care facilities industry, commands attention with a market capitalization of $87.42 billion. Based in Nashville, Tennessee, this healthcare behemoth operates..

Biogen Inc. (BIIB) Stock Analysis: Navigating a Potential 13% Upside Amidst Robust Drug Pipeline

Biogen Inc. (NASDAQ: BIIB), a stalwart in the healthcare sector, stands as a significant player within the general drug manufacturing industry. With a current market capitalization of $28.61 billion, Biogen..

Atrium Therapeutics, Inc. (RNA) Stock Analysis: Exploring a 90.99% Potential Upside in RNA Therapeutics

Atrium Therapeutics, Inc. (NASDAQ: RNA) is capturing investor attention with a remarkable potential upside of 90.99%, according to recent analyst ratings. This San Diego-based biopharmaceutical company is pioneering the development..

Quest Diagnostics (DGX) Stock Analysis: Exploring a 14.46% Potential Upside in the Diagnostics Sector

Quest Diagnostics Incorporated (NYSE: DGX), a key player in the Healthcare sector, specifically within the Diagnostics & Research industry, is currently garnering significant attention from investors. With a market capitalization..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds